Related Experiment Video

Updated: Jun 29, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

Ying Jiang1, Andrew Dunbar, Lukasz P Gondek

  • 1Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Cleveland Clinic, OH 44195, USA.

Blood
|October 4, 2008
PubMed

Insights

Aberrant DNA methylation is the primary driver of tumor-suppressor gene silencing in myelodysplastic syndromes (MDS) progression to acute myeloid leukemia (AML). This epigenetic mechanism, alongside chromosomal deletions, contributes to neoplastic evolution.

Area of Science:

  • Hematology
  • Cancer Biology
  • Epigenetics

Background:

  • Myelodysplastic syndromes (MDS) are clonal hematologic disorders.
  • MDS can progress to acute myeloid leukemia (AML), representing a critical stage of neoplastic evolution.

Purpose of the Study:

  • To investigate the roles of aberrant DNA methylation and chromosomal deletions in tumor-suppressor gene (TSG) silencing during MDS progression to AML.
  • To identify key genes and mechanisms driving clonal variation and disease evolution.

Main Methods:

  • DNA methylation microarray and high-density single nucleotide polymorphism array (SNP-A) karyotyping were performed on 184 patients with MDS and AML.
  • Analysis focused on assessing the extent and distribution of aberrant methylation and chromosomal aberrations.
  • Candidate TSGs were identified through analysis of frequently methylated genes.

Main Results:

  • Aberrant DNA methylation was ubiquitous, affecting a significant number of CpG loci and increasing with disease progression (from 91 to 179 loci).
  • Chromosomal aberrations were frequent (79-90%) but less widely distributed than methylation changes.
  • FZD9 was identified as a candidate TSG on chromosome 7, with methylation of the remaining allele in deleted cases correlating with poor outcomes.

Conclusions:

  • Aberrant DNA methylation is the dominant mechanism for TSG silencing and clonal variation in MDS evolution to AML.
  • Aberrant methylation cooperates with chromosomal deletions to silence TSGs, influencing clinical outcomes.
  • Understanding these mechanisms offers insights into neoplastic evolution in hematologic disorders.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...